Inventor
FRANCESCA VITI
Inventor
CH
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07CAcyclic or carbocyclic compounds24%
C07DHeterocyclic compounds10%
C07BGeneral methods of organic chemistry7%
C12NMicroorganisms or enzymes3%
PatentTitleYear
12,577,256Aryl receptor modulators and methods of making and using the same202612,509,416Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof202512,291,494Methods of treating fibrosis202512,071,623IL-34 antisense agents and methods of using same202412,012,418Aryl receptor modulators and methods of making and using the same202411,905,232Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof202411,753,365Methods of treating fibrosis202311,427,600Aryl receptor modulators and methods of making and using the same2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to NOGRA PHARMA LTD (8)· patent assignee history
2022–2026Based in CH· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOGRA PHARMA LTD | 8 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| CH | 8 | 2022–2026 |